₹ 129 - ₹ 136
03-Jun-2024 - 05-Jun-2024
₹ 14960.00



03-Jun-2024 - 05-Jun-2024

₹ 129 - ₹ 136

Price Band

₹ 14960.00

Minimum Investment


Bid Lot


  • Face Value - ₹ 10/- Per Share

  • Listing at NSE BSE

  • 30,450 Application Required in Retail for 1 Time.

  • Registrar : KFin Technologies Limited

IPO Details

Offer for Sale Up to 95,70,000 Equity Shares

Category % Shares/Amount
QIB 50% 4,785,000 Shares Rs.65.08 Cr
HNI 1 5% 478,000 Shares Rs.6.51 Cr @ 311 Form 1X
HNI 2 15% 957,000 Shares Rs.13.02 Cr @ 621 Form 1X
Retail 35% 3,349,500 Shares Rs. 45.35 Cr @ 30450 Form 1X

BRLMs: Pantomath Capital Advisors

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
30450 Form 1X 311 Form 1X 621 Form 1X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 110 ₹ 14,960
Retail (Upto 2 Lakh) 13 1430 ₹ 194,480
S-HNI (2 Lakh to 10 Lakh) 14 1540 ₹ 209,440
S-HNI (2 Lakh to 10 Lakh) 66 7260 ₹ 987,360
B-HNI (Above 10 Lakh) 67 7370 ₹ 1,002,320

IPO Timeline

  • Open Date

  • Close Date

  • Basis of Allotment Date

  • Initiation of Refunds

  • Credit Shares to Demat A/c

  • IPO Listing Date


Subscription as on
05-Jun-2024 16:56

Category Book Size Subscription No. of Times
QIB 1,914,000 ₹ 26.03 Cr. 170,409,360 ₹ 2317.57 Cr. 89.03x
HNI (<10 LAKH) 478,000 ₹ 6.50 Cr. 124,937,450 ₹ 1699.15 Cr. 261.38x
HNI2 (>10 LAKH) 957,000 ₹ 13.02 Cr. 308,406,670 ₹ 4194.33 Cr. 322.26x
RETAIL 3,349,500 ₹ 45.55 Cr. 181,180,670 ₹ 2464.06 Cr. 54.09x
Total 6,698,500 784,934,150 117.18x
Category Book Size Subscription No. of Times
QIB 1,914,000 ₹ 26.03 Cr. 170,409,360 ₹ 2317.57 Cr. 89.03x
HNI (<10 LAKH) 478,000 ₹ 6.50 Cr. 124,937,450 ₹ 1699.15 Cr. 261.38x
HNI2 (>10 LAKH) 957,000 ₹ 13.02 Cr. 308,406,670 ₹ 4194.33 Cr. 322.26x
RETAIL 3,349,500 ₹ 45.55 Cr. 181,180,670 ₹ 2464.06 Cr. 54.09x
Total 6,698,500 784,934,150 117.18x

*Excluding Anchor

Total No. of Application Approx : ~1474225 (48.41 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  • The Company was incorporated as 'Kronox Lab Sciences Pvt. Ltd on November 18, 2008, at Gujarat and subsequently the name was changed to 'Kronox Lab Sciences Ltd' on May 25, 2019, on conversion to a public limited company. The company manufactures High Purity Speciality Fine Chemicals for diversified end user industries which include pharmaceuticals, scientific and laboratory research, nutraceuticals, biotech, agrochemicals, personal care, metallurgy and animal health.
  • The company manufactures High Purity Speciality Fine Chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh. The company’s 185+ products span across the family of phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, among others. Moreover, as on December 31, 2023, the company had 122 products under various phases of research and development.
  • The products are manufactured in accordance with industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR and ACS in addition to custom manufacturing specifications required by customers in select cases.
  • The company has 3 manufacturing facilities spread over 17,454 sq. meters, having an aggregate installed capacity of 7,242 TPA, which are situated at Vadodara in Gujarat close to the seaports of Mundra, Kandla, Hazira and Nhava Sheva. Further, the company intends to establish a new manufacturing unit at GIDC Dahej – II Industrial Estate and the company has acquired land admeasuring to 20,471 sq. meters for the said facility.
  • The company has served more than 592 customers in the last 3 financial years and during the 9 months period ended December 31, 2023, of which 141 customers amounting to 23.82% of total customers placed repeat orders. Further, the average tenure of the relationship with its top 10 customers is 7 years, 9 years and 9 years for Fiscals 2023, 2022 and 2021, respectively.
  • The company’s Revenues from operations grew at CAGR of 23.70% between Fiscal 2021 to 2023, from ? 62.46 Cr to ? 95.58 Cr, while its EBITDA grew at a CAGR of 21.90% from ? 14.80 Cr to ? 21.99 Cr during the same period. The company’s PAT grew at a CAGR of 30.68% between Fiscal 2021 to Fiscal 2023 from ? 9.73 Cr to ? 16.62 Cr. Further the company is a zero debt company with a strong balance sheet balance sheet and cash flow position.
Read More


Competitive Strength 

  • Wide range of products finding applications in diversified end user industries;
  • Long standing relationships with customers;
  • High entry and exit barriers due to long customer approval cycles and strict product standards;
  • Focus on R&D and Quality Control;
  • Zero debt company with strong and consistent financial performance;
  • Strategically located manufacturing facilities providing supply chain efficiencies;
  • Experienced Promoters and Senior Management with extensive domain knowledge.

 Business Strategies 

  • Expand product portfolio, increasing the supply of products to existing customers and tap new customers in existing and new geographies;
  • Expand the capacity for existing products and diversifying into new products by setting up a new manufacturing facility;
  • Explore newer applications for the existing products and developing new products that are in synergy with the current and future operations;
  • Focus on import substitution and increasing exports;
  • Improve cost management and operational efficiencies.

Company Promoters

Jogindersingh Jaswal is one of the Promoters and is the MD of the Company. Ketan Ramani is one of the Promoters and Whole-time Director of the Company. Pritesh Ramani is one of the Promoters and Whole-time Director of the Company. Satish Kumar has been an Independent Director of the company since August 23, 2022. Krutika Negandhi has been an Independent Director of the Company since August 23, 2022. She Parth Shah has been an Independent Director of the Company since August 23, 2022. Samir

Company Financials

Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended 31 Dec 2023 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets 66.96 54.03 56.79 37.65
Revenue 68.44 97.50 83.34 63.24
Profit After Tax 15.47 16.62 13.63 9.73
Net Worth 60.28 44.68 40.35 26.81
Reserves and Surplus 15.56 7.58 40.11 26.57
Total Borrowing     0.64 0.01
Amount in ? Crore

Objects of the Issue

The Objects of the Offer are to:

  1. Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
  2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to Us.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with Us, in just a few clicks your application is processed. You can bid for any IPO through Us, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment